NGS overcomes obstacles in leukaemia testing

By Vela

Diagnosis of leukaemia involves a number of pathology disciplines, followed by further procedures to identify the type of leukaemia it may be. Next-generation sequencing does offer benefits for the diagnostics, but comes with its own obstacles. Vela Diagnostics has specifically developed its Sentosa NGS system to meet the requirements of routine molecular diagnostics applications.

Enter your details below to view the free white paper

By downloading this White Paper, you acknowledge that may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how Business Trade Media International Limited may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.